Chelohart delivers heart-specific Bosom Peptides that interact with cardiac myocytes at the epigenetic level. By restoring age-depleted peptide signals in the myocardium, it supports contractile strength, coronary microcirculation, and overall cardiac resilience.
Chelohart is a precision-engineered bioregulator peptide that selectively targets cardiac muscle through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within cardiac muscle cells, Chelohart helps normalise myocardial contractility and coronary microcirculation—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for cardiovascular tissue maintenance, making it a fundamentally different approach from conventional supplementation.